Theravance Biopharma Inc
Biotechnology
Healthcare
TBPH
49.00 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
10.66
52 week high
11.25
high
10.71
52 week low
7.93
previous Close
10.67
P/E ratio
market cap
472 M
div yield
0
net incoming
-12.70 M
23.18 %
net profit margin
-75.28 %
40.00 %
operating incoming
-10.84 M
15.03 %
net change in cash
-22.97 M
-206.64 %
cash on hand
23.38 M
-49.56 %
top